ARTICLE | Company News
Bio-Technology General other research news
March 1, 1993 8:00 AM UTC
Bio-Technology General Corp. (BTGC) Product: Recombinant superoxide dismutase Indication: Prevent bronchopulmonary dysplasia in premature neonates Status: Will begin Phase I trial ...